Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells
Authors
Keywords
-
Journal
Immunotherapy
Volume 9, Issue 5, Pages 387-400
Publisher
Future Medicine Ltd
Online
2017-03-30
DOI
10.2217/imt-2017-0008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, purification and assessment of GRP78 binding peptide-linked Subunit A of Subtilase cytotoxic for targeting cancer cells
- (2016) Lichao Zhang et al. BMC BIOTECHNOLOGY
- Immunogenicity of therapeutic recombinant immunotoxins
- (2016) Ronit Mazor et al. IMMUNOLOGICAL REVIEWS
- Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
- (2016) Frieder Bauss et al. Molecular Oncology
- High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries
- (2016) Shin-Chen Hou et al. Scientific Reports
- An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
- (2015) Ruth E. Soria-Guerra et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Development of Human Serine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC
- (2014) H. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
- (2014) K. Hollevoet et al. MOLECULAR CANCER THERAPEUTICS
- Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts
- (2014) Ludmilla de Plater et al. PLoS One
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
- (2013) H. Zhou et al. CANCER RESEARCH
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- In Silico Approach for Predicting Toxicity of Peptides and Proteins
- (2013) Sudheer Gupta et al. PLoS One
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) F. Cardoso et al. ANNALS OF ONCOLOGY
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rise and Demise of Bioinformatics? Promise and Progress
- (2012) Christos A. Ouzounis PLoS Computational Biology
- Therapeutic potential of anticancer immunotoxins
- (2011) Swati Choudhary et al. DRUG DISCOVERY TODAY
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia
- (2011) Robert J. Kreitman et al. LEUKEMIA & LYMPHOMA
- Development and Characterization of a Potent Immunoconjugate Targeting the Fn14 Receptor on Solid Tumor Cells
- (2011) H. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity
- (2011) W. Liu et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties
- (2010) Christopher M. Pirie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
- (2009) Y Andersson et al. BRITISH JOURNAL OF CANCER
- Codon usage bias is correlated with gene expression levels in the fission yeastSchizosaccharomyces pombe
- (2009) Yasushi Hiraoka et al. GENES TO CELLS
- Roles of β-turns in protein folding: From peptide models to protein engineering
- (2008) Anna Marie C. Marcelino et al. BIOPOLYMERS
- Bringing Web 2.0 to bioinformatics
- (2008) Z. Zhang et al. BRIEFINGS IN BIOINFORMATICS
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation
- (2008) A. B. Lindner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now